Titre : Protéines Escherichia coli

Protéines Escherichia coli : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gain of Function Mutation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines Escherichia coli : Questions médicales les plus fréquentes", "headline": "Protéines Escherichia coli : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines Escherichia coli : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-28", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines Escherichia coli" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines bactériennes", "url": "https://questionsmedicales.fr/mesh/D001426", "about": { "@type": "MedicalCondition", "name": "Protéines bactériennes", "code": { "@type": "MedicalCode", "code": "D001426", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.097" } } }, "about": { "@type": "MedicalCondition", "name": "Protéines Escherichia coli", "alternateName": "Escherichia coli Proteins", "code": { "@type": "MedicalCode", "code": "D029968", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peter L Freddolino", "url": "https://questionsmedicales.fr/author/Peter%20L%20Freddolino", "affiliation": { "@type": "Organization", "name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan, United States of America." } }, { "@type": "Person", "name": "Lei Yin", "url": "https://questionsmedicales.fr/author/Lei%20Yin", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Epidemic Diseases Research Center of Anhui Province, Institute of Animal Husbandry and Veterinary Science, Anhui Academy of Agricultural Sciences, Hefei, Anhui 230031, China." } }, { "@type": "Person", "name": "Xiaocheng Pan", "url": "https://questionsmedicales.fr/author/Xiaocheng%20Pan", "affiliation": { "@type": "Organization", "name": "Livestock and Poultry Epidemic Diseases Research Center of Anhui Province, Institute of Animal Husbandry and Veterinary Science, Anhui Academy of Agricultural Sciences, Hefei, Anhui 230031, China. Electronic address: pxcpyq@sina.com." } }, { "@type": "Person", "name": "Kezong Qi", "url": "https://questionsmedicales.fr/author/Kezong%20Qi", "affiliation": { "@type": "Organization", "name": "Anhui Province Key Laboratory of Veterinary Pathobiology and Disease Control, College of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, PR China. Electronic address: qkz@ahau.edu.cn." } }, { "@type": "Person", "name": "Eduardo A Ceccarelli", "url": "https://questionsmedicales.fr/author/Eduardo%20A%20Ceccarelli", "affiliation": { "@type": "Organization", "name": "Instituto de Biología Molecular y Celular de Rosario (IBR), CONICET, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Construction and validation of a colon cancer prognostic model based on tumor mutation burden-related genes.", "datePublished": "2024-02-04", "url": "https://questionsmedicales.fr/article/38311637", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-53257-z" } }, { "@type": "ScholarlyArticle", "name": "LDLR gene rearrangements in Czech FH patients likely arise from one mutational event.", "datePublished": "2024-02-02", "url": "https://questionsmedicales.fr/article/38308247", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12944-024-02013-3" } }, { "@type": "ScholarlyArticle", "name": "BRCA mutation patients: are there other predisposing factors for ovarian cancer occurrence? A multicentre retrospective study.", "datePublished": "2024-01-19", "url": "https://questionsmedicales.fr/article/38246147", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000535012" } }, { "@type": "ScholarlyArticle", "name": "Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with Phe508del mutation: Evidence from randomized controlled trials.", "datePublished": "2024-01-18", "url": "https://questionsmedicales.fr/article/38249954", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/20503121231225874" } }, { "@type": "ScholarlyArticle", "name": "Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations.", "datePublished": "2024-01-12", "url": "https://questionsmedicales.fr/article/38256054", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms25020980" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines bactériennes", "item": "https://questionsmedicales.fr/mesh/D001426" }, { "@type": "ListItem", "position": 5, "name": "Protéines Escherichia coli", "item": "https://questionsmedicales.fr/mesh/D029968" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines Escherichia coli - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines Escherichia coli", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines Escherichia coli", "description": "Comment diagnostiquer une infection par E. coli ?\nQuels tests sont utilisés pour détecter les protéines E. coli ?\nQuels symptômes indiquent une infection par E. coli ?\nLes tests sanguins sont-ils utiles pour E. coli ?\nComment différencier E. coli des autres bactéries ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Gain+of+Function+Mutation&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines Escherichia coli", "description": "Quels sont les symptômes d'une intoxication alimentaire par E. coli ?\nE. coli peut-elle causer des infections urinaires ?\nQuels signes indiquent une infection grave par E. coli ?\nLes symptômes d'E. coli varient selon le type ?\nComment les symptômes d'E. coli se manifestent-ils chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Gain+of+Function+Mutation&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines Escherichia coli", "description": "Comment prévenir les infections à E. coli ?\nLes aliments crus sont-ils un risque pour E. coli ?\nLe lavage des mains réduit-il le risque d'E. coli ?\nFaut-il cuire la viande pour éviter E. coli ?\nLes voyages augmentent-ils le risque d'infection par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Gain+of+Function+Mutation&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines Escherichia coli", "description": "Quel est le traitement standard pour une infection par E. coli ?\nLes antibiotiques sont-ils toujours nécessaires pour E. coli ?\nComment traiter la déshydratation due à E. coli ?\nY a-t-il des traitements spécifiques pour les souches E. coli pathogènes ?\nLes probiotiques aident-ils après une infection par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Gain+of+Function+Mutation&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines Escherichia coli", "description": "Quelles sont les complications possibles d'une infection par E. coli ?\nE. coli peut-elle causer des complications rénales ?\nComment les complications d'E. coli sont-elles traitées ?\nLes complications d'E. coli sont-elles fréquentes ?\nQuels facteurs augmentent le risque de complications par E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Gain+of+Function+Mutation&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines Escherichia coli", "description": "Quels sont les principaux facteurs de risque d'infection par E. coli ?\nLes personnes âgées sont-elles plus à risque d'E. coli ?\nLes enfants sont-ils plus vulnérables aux infections à E. coli ?\nLe système immunitaire affaibli augmente-t-il le risque d'E. coli ?\nLes voyages à l'étranger augmentent-ils le risque d'E. coli ?", "url": "https://questionsmedicales.fr/mesh/D029968?mesh_terms=Gain+of+Function+Mutation&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par E. coli ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par culture bactérienne et tests de sensibilité aux antibiotiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les protéines E. coli ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests immunologiques et des techniques de biologie moléculaire sont utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection par E. coli ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée, douleurs abdominales et parfois fièvre." } }, { "@type": "Question", "name": "Les tests sanguins sont-ils utiles pour E. coli ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent détecter des signes d'infection systémique." } }, { "@type": "Question", "name": "Comment différencier E. coli des autres bactéries ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biochimiques spécifiques et des méthodes moléculaires permettent cette différenciation." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication alimentaire par E. coli ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des crampes abdominales, diarrhée sanglante et vomissements." } }, { "@type": "Question", "name": "E. coli peut-elle causer des infections urinaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, E. coli est une cause fréquente d'infections urinaires, provoquant douleur et brûlures." } }, { "@type": "Question", "name": "Quels signes indiquent une infection grave par E. coli ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la déshydratation sévère, la confusion ou la fièvre élevée sont préoccupants." } }, { "@type": "Question", "name": "Les symptômes d'E. coli varient selon le type ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, différents types d'E. coli peuvent provoquer des symptômes variés, allant de légers à graves." } }, { "@type": "Question", "name": "Comment les symptômes d'E. coli se manifestent-ils chez les enfants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Chez les enfants, les symptômes peuvent inclure diarrhée, vomissements et irritabilité." } }, { "@type": "Question", "name": "Comment prévenir les infections à E. coli ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par une bonne hygiène alimentaire et le lavage des mains." } }, { "@type": "Question", "name": "Les aliments crus sont-ils un risque pour E. coli ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les aliments crus, notamment la viande et les légumes, peuvent être contaminés par E. coli." } }, { "@type": "Question", "name": "Le lavage des mains réduit-il le risque d'E. coli ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un lavage des mains régulier réduit significativement le risque d'infection." } }, { "@type": "Question", "name": "Faut-il cuire la viande pour éviter E. coli ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cuire la viande à la bonne température élimine le risque d'infection par E. coli." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection par E. coli ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des régions à risque peuvent augmenter l'exposition à E. coli." } }, { "@type": "Question", "name": "Quel est le traitement standard pour une infection par E. coli ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut l'hydratation et, dans certains cas, des antibiotiques." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils toujours nécessaires pour E. coli ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas toujours recommandés, surtout pour les souches productrices de toxines." } }, { "@type": "Question", "name": "Comment traiter la déshydratation due à E. coli ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation est traitée par des solutions de réhydratation orale ou intraveineuse." } }, { "@type": "Question", "name": "Y a-t-il des traitements spécifiques pour les souches E. coli pathogènes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches nécessitent des traitements spécifiques basés sur leur résistance aux antibiotiques." } }, { "@type": "Question", "name": "Les probiotiques aident-ils après une infection par E. coli ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques peuvent aider à restaurer la flore intestinale après une infection." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection par E. coli ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le syndrome hémolytique et urémique, et des infections systémiques." } }, { "@type": "Question", "name": "E. coli peut-elle causer des complications rénales ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines souches d'E. coli peuvent entraîner des complications rénales graves." } }, { "@type": "Question", "name": "Comment les complications d'E. coli sont-elles traitées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement des complications peut nécessiter des soins intensifs et des interventions médicales." } }, { "@type": "Question", "name": "Les complications d'E. coli sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout chez les personnes vulnérables." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications par E. coli ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les jeunes enfants, les personnes âgées et celles avec un système immunitaire affaibli sont à risque." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'infection par E. coli ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent la consommation d'aliments contaminés et le contact avec des animaux." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque d'E. coli ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru d'infections graves par E. coli." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux infections à E. coli ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants sont plus susceptibles de développer des infections graves." } }, { "@type": "Question", "name": "Le système immunitaire affaibli augmente-t-il le risque d'E. coli ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un système immunitaire affaibli augmente le risque d'infections et de complications." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque d'E. coli ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des pays avec des normes sanitaires faibles augmente le risque d'infection." } } ] } ] }

Sources (10000 au total)

LDLR gene rearrangements in Czech FH patients likely arise from one mutational event.

Large deletions and duplications within the low-density lipoprotein receptor (LDLR) gene make up approximately 10% of LDLR pathogenic variants found in Czech patients with familial hypercholesterolemi... The breakpoint sequence was determined by PCR amplification and Sanger sequencing. To confirm the breakpoint position, an NGS analysis was performed. Haplotype analysis of common LDLR variants was per... The breakpoints of 8 rearrangements within the LDLR gene were analysed, including the four most common LDLR rearrangements in the Czech population (number of probands ranging from 8 to 28), and four l... The most common rearrangements of the LDLR gene in the Czech population likely arose from one mutational event. Alu elements likely played a role in the generation of the majority of rearrangements in...

BRCA mutation patients: are there other predisposing factors for ovarian cancer occurrence? A multicentre retrospective study.

The objective of this multicenter retrospective study aimed to evaluate the association of clinical variables and the incidence of ovarian cancer in patients with BRCA 1-2 mutation carriers who underw... Patients with a pathogenic mutation of BRCA 1-2 genes and with no evidence of disease are considered eligible. The exclusion criterion was the refusal to undergo the surgery. The retrospective study i... Age, menarche age, BMI, menopause at time of RRSO, breast cancer first and second-degree relatives, ovarian cancer first and second-degree relatives, estroprogestin use, pregnancy normal full-term del... 184 were recruited. One was excluded. To assess cancer risk, the outcome variable was classified into three classes: no event, cancer and other conditions excluding cancer. 14 women presented ovarian ... Our study did not demonstrate a correlation between clinical features and the occurrence of precancerous or cancerous lesions in BRCA mutation carrier patients....

Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with Phe508del mutation: Evidence from randomized controlled trials.

This study aimed to conduct a systematic review and meta-analysis of randomized controlled trials to evaluate the effects of elexacaftor-tezacaftor-ivacaftor (ELX-TEZ-IVA) on patients with cystic fibr... A systematic search was performed in PubMed, Embase, and the Cochrane Library from inception to August 1, 2022. Meta-analysis was conducted using Review Manager 5.3 software.... Six studies comprising seven reports involving a total of 1125 CF patients were included. The meta-analyses indicated that ELX-TEZ-IVA significantly improved the percentage predicted forced expiratory... ELX-TEZ-IVA demonstrated efficacy in improving ppFEV1, CFQ-R RD, and sweat chloride concentrations in patients with CF. However, caution should be exercised regarding the incidence of AEs, particularl...

PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients.

Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic disease characterized by the accumulation of fluid-filled cysts in the kidneys, leading to renal volume enlargement and progressive ... We established a single center retrospective cohort study in Kuwait where we followed every patient with a confirmed PKD1-ADPKD diagnosis clinically and genetically. Renal function tests were performe... The study included 22 truncating and 20 non-truncating (42 total) patients followed for an average of 6.6 years (range: 1 to 12 years). Those with PKD1 truncating mutations had a more rapid rate of eG... In longitudinal and survival analyses, patients with PKD1 truncating mutations showed a faster decline in kidney function compared to patients PKD1 non-truncating mutations. Early identification of pa...

Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study.

There is preliminary evidence suggesting that FCR is a major problem for breast cancer survivors carrying a BRCA1/2 mutation. The goal of this qualitative study, conducted among women who were treated... Three focus groups (90-110 min) were conducted with 19 breast cancer survivors carrying a BRCA1/2 mutation. The semistructured interview probed FCR level and impact, the role FCR played in the decisio... Findings indicated that FCR was a significant issue in these women, even though a majority had undergone a prophylactic surgery. Patients strongly affirmed the need to develop and provide access to FC... These results suggest that, although being the most effective medical option to reduce the actual risk of local recurrence (or second breast cancer), prophylactic surgery only partially reduces FCR. A...